Cell & Gene Therapy Medical Affairs Summit

As the cell and gene therapy landscape advances, underscored by recent approvals from leaders like Bristol Myers Squibb and Orchard Therapeutics, the role of medical affairs professionals is becoming increasingly indispensable. They bridge the gap between industry and the medical community, united in their mission to enhance patient outcomes.

Introducing the Cell & Gene Therapy Medical Affairs Summit, the premier event highlighting the essential role of medical affairs in delivering therapies to patients. Explore how traditional approaches are being revolutionized to tackle the unique challenges of cell and gene therapy drug development. Here, the fusion of scientific and clinical expertise with strategic commercial vision creates opportunities for transformative breakthroughs!

Whether you’re nearing IND submission or preparing for BLA approval, this gathering of brilliant minds offers unparalleled networking and insights from organizations like Adaptimmune, Autolus Therapeutics, Bristol Myers Squibb, bluebird bio, Caribou Biosciences, Editas Medicine, Orchard Therapeutics, and more.